Squarepoint Ops LLC Bristol Myers Squibb CO Call Options Transaction History

Squarepoint Ops LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $32.4 Million - $42.6 Million	-804,200 Reduced 69.85%	347,200 $14.4 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $40.6 Million - $46 Million	845,500 Added 276.4%	1,151,400 $62.4 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $6.83 Million - $8.15 Million	140,800 Added 85.28%	305,900 $15.7 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $401,373 - $445,661	6,300 Added 3.97%	165,100 $10.6 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $3.4 Million - $3.86 Million	51,800 Added 48.41%	158,800 $11 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $1.33 Million - $1.57 Million	19,400 Added 22.15%	107,000 $7.7 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $637 - $376,516	4,900 Added 5.93%	87,600 $6.23 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $370,362 - $407,898	5,100 Added 6.57%	82,700 $6.37 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $4.42 Million - $5.3 Million	71,900 Added 1261.4%	77,600 $5.67 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.95 Million - $2.27 Million	-36,300 Reduced 86.43%	5,700 $355,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1.23 Million - $1.33 Million	19,800 Added 89.19%	42,000 $2.81 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1.07 Million - $1.22 Million	18,600 Added 516.67%	22,200 $1.38 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $93,499 - $121,961	-1,900 Reduced 34.55%	3,600 $231,000
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $235,235 - $278,905	5,500 New	5,500 $279,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.